Skip to content
★ Sign in to follow
FG

Francesco Granata

Executive
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€215k

Latest filing published 03 Feb 2012 for BIOGEN INC..

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Francesco Granata: trading record in brief

Francesco Granata appears in our data through filings on Biogen Inc. shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 1 February 2011 and the latest from 1 February 2012.

The open-market record consists of 1 sale worth €215k, with no purchase. Besides market trades, the filings include 3 share grants and 3 option exercises.

The record was last updated on 3 February 2012 with an option exercise in Biogen Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Francesco Granata

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◇
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    0SEC
    5,198 shares0Common StockSEC:0001127602-12-003918:0
  • ◆
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    202,383 USD0SEC
    1,669 shares@ US$121.26Common StockSEC:0001127602-12-003918:1
  • ▼
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    311,916 USD0SEC
    2,901 shares@ US$107.52Common StockSEC:0001127602-11-020299:0
  • ◇
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    0SEC
    3,465 shares0Common StockSEC:0001127602-11-003750:0
  • ◇
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    0SEC
    821 shares0Common StockSEC:0001127602-11-003750:1
  • ◆
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    73,611 USD0SEC
    1,124 shares@ US$65.49Common StockSEC:0001127602-11-003750:2
  • ◆
    EVP Global Commercial OperatioExecutivesBiogen Inc.
    17,093 USD0SEC
    261 shares@ US$65.49Common StockSEC:0001127602-11-003750:3

7 of 7 declarations